The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells

3-bromopyruvate (3-BP) is a small molecule with anticancer and antimicrobial activities. 3-BP is taken up selectively by cancer cells’ mono-carboxylate transporters (MCTs), which are highly overexpressed by many cancers. When 3-BP enters cancer cells it inactivates several glycolytic and mitochondri...

Full description

Bibliographic Details
Main Authors: Magdalena Cal, Irwin Matyjaszczyk, Ireneusz Litwin, Daria Augustyniak, Rafał Ogórek, Young Ko, Stanisław Ułaszewski
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/5/1161
_version_ 1797568547321282560
author Magdalena Cal
Irwin Matyjaszczyk
Ireneusz Litwin
Daria Augustyniak
Rafał Ogórek
Young Ko
Stanisław Ułaszewski
author_facet Magdalena Cal
Irwin Matyjaszczyk
Ireneusz Litwin
Daria Augustyniak
Rafał Ogórek
Young Ko
Stanisław Ułaszewski
author_sort Magdalena Cal
collection DOAJ
description 3-bromopyruvate (3-BP) is a small molecule with anticancer and antimicrobial activities. 3-BP is taken up selectively by cancer cells’ mono-carboxylate transporters (MCTs), which are highly overexpressed by many cancers. When 3-BP enters cancer cells it inactivates several glycolytic and mitochondrial enzymes, leading to ATP depletion and the generation of reactive oxygen species. While mechanisms of 3-BP uptake and its influence on cell metabolism are well understood, the impact of 3-BP at certain concentrations on DNA integrity has never been investigated in detail. Here we have collected several lines of evidence suggesting that 3-BP induces DNA damage probably as a result of ROS generation, in both yeast and human cancer cells, when its concentration is sufficiently low and most cells are still viable. We also demonstrate that in yeast 3-BP treatment leads to generation of DNA double-strand breaks only in S-phase of the cell cycle, possibly as a result of oxidative DNA damage. This leads to DNA damage, checkpoint activation and focal accumulation of the DNA response proteins. Interestingly, in human cancer cells exposure to 3-BP also induces DNA breaks that trigger H2A.X phosphorylation. Our current data shed new light on the mechanisms by which a sufficiently low concentration of 3-BP can induce cytotoxicity at the DNA level, a finding that might be important for the future design of anticancer therapies.
first_indexed 2024-03-10T19:58:30Z
format Article
id doaj.art-8168ad7a51fb4b16aaeba53ded80a652
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T19:58:30Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-8168ad7a51fb4b16aaeba53ded80a6522023-11-19T23:46:50ZengMDPI AGCells2073-44092020-05-0195116110.3390/cells9051161The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer CellsMagdalena Cal0Irwin Matyjaszczyk1Ireneusz Litwin2Daria Augustyniak3Rafał Ogórek4Young Ko5Stanisław Ułaszewski6Department of Mycology and Genetics, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, PolandDepartment of Mycology and Genetics, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, PolandDepartment of Genetics and Cellular Physiology, Institute of Experimental Biology, University of Wroclaw, 50-328 Wroclaw, PolandDepartment of Pathogen Biology and Immunology, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, PolandDepartment of Mycology and Genetics, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, PolandKoDiscovery, LLC, UM BioPark, Baltimore, MD 21201, USADepartment of Mycology and Genetics, Institute of Genetics and Microbiology, University of Wroclaw, 51-148 Wroclaw, Poland3-bromopyruvate (3-BP) is a small molecule with anticancer and antimicrobial activities. 3-BP is taken up selectively by cancer cells’ mono-carboxylate transporters (MCTs), which are highly overexpressed by many cancers. When 3-BP enters cancer cells it inactivates several glycolytic and mitochondrial enzymes, leading to ATP depletion and the generation of reactive oxygen species. While mechanisms of 3-BP uptake and its influence on cell metabolism are well understood, the impact of 3-BP at certain concentrations on DNA integrity has never been investigated in detail. Here we have collected several lines of evidence suggesting that 3-BP induces DNA damage probably as a result of ROS generation, in both yeast and human cancer cells, when its concentration is sufficiently low and most cells are still viable. We also demonstrate that in yeast 3-BP treatment leads to generation of DNA double-strand breaks only in S-phase of the cell cycle, possibly as a result of oxidative DNA damage. This leads to DNA damage, checkpoint activation and focal accumulation of the DNA response proteins. Interestingly, in human cancer cells exposure to 3-BP also induces DNA breaks that trigger H2A.X phosphorylation. Our current data shed new light on the mechanisms by which a sufficiently low concentration of 3-BP can induce cytotoxicity at the DNA level, a finding that might be important for the future design of anticancer therapies.https://www.mdpi.com/2073-4409/9/5/11613-bromopyruvateDNA damageDNA double-strand breakoxidative stressyeasthuman monocytes
spellingShingle Magdalena Cal
Irwin Matyjaszczyk
Ireneusz Litwin
Daria Augustyniak
Rafał Ogórek
Young Ko
Stanisław Ułaszewski
The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
Cells
3-bromopyruvate
DNA damage
DNA double-strand break
oxidative stress
yeast
human monocytes
title The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
title_full The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
title_fullStr The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
title_full_unstemmed The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
title_short The Anticancer Drug 3-Bromopyruvate Induces DNA Damage Potentially Through Reactive Oxygen Species in Yeast and in Human Cancer Cells
title_sort anticancer drug 3 bromopyruvate induces dna damage potentially through reactive oxygen species in yeast and in human cancer cells
topic 3-bromopyruvate
DNA damage
DNA double-strand break
oxidative stress
yeast
human monocytes
url https://www.mdpi.com/2073-4409/9/5/1161
work_keys_str_mv AT magdalenacal theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT irwinmatyjaszczyk theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT ireneuszlitwin theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT dariaaugustyniak theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT rafałogorek theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT youngko theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT stanisławułaszewski theanticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT magdalenacal anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT irwinmatyjaszczyk anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT ireneuszlitwin anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT dariaaugustyniak anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT rafałogorek anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT youngko anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells
AT stanisławułaszewski anticancerdrug3bromopyruvateinducesdnadamagepotentiallythroughreactiveoxygenspeciesinyeastandinhumancancercells